 NESS ZIONA, Israel--BUSINESS WIRE--BiomX Inc. NYSE American: PHGE BiomX or the Company, a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer of BiomX, will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022. H.C Wainwright Global Investment Conference September 12-14, 2022 Date Time: Mond 